Antitumor activity of TAK-788 in NSCLC With EGFR exon 20 insertions

Janne, PA; Neal, JW; Camidge, DR; Spira, A; Piotrowska, Z; Horn, L; Costa, DB; Tsao, A; Patel, J; Gadgeel, S; Bazhenova, L; Zhu, VW; West, H; Vincent, S; Zhu, J; Li, SL; Riely, GJ

ANNALS OF ONCOLOGY, 2019; 30 ():